Sarepta International Holdings GmbH
Biotechnology · Zug, Zug
Sarepta International Holdings GmbH is a Swiss biotechnology company based in Zug, Canton of Zug, listed in the Swiss commercial register since 2017 (UID CHE-319.605.632).
Board members & signatories
- Silvia Contreras Hediger — Geschäftsführer
- Silvia Maeder — Geschäftsführer
- Joseph Bratica — Vorsitzender der Geschäftsführung
Registered purpose
Forschung, Entwicklung, Herstellung und Handel auf dem Gebiet von medizinisch-pharmazeutischen Produkten, Erbringung damit zusammenhängender Dienstleistungen sowie Halten und Verwalten von Beteiligungen; vollständige Zweckumschreibung gemäss Statuten…
Source: Swiss commercial register (Zefix / SOGC) and Alpintel analysis · Data as of March 2026
What Sarepta International Holdings does
OFFERING
Sarepta International Holdings GmbH focuses on developing genetic medicines for rare diseases, particularly Duchenne muscular dystrophy, limb-girdle muscular dystrophy, and Charcot-Marie-Tooth disease. Their platforms include gene therapy, RNA technologies, and gene editing, with a commitment to building significant gene therapy manufacturing capacity.
Unlock the full analysis →Similar companies
- SEAL Therapeutics AG — Biotechnology · Basel
- Ultragenyx Europe GmbH — Biotechnology · Basel
- Biogen International GmbH — Biotechnology · Baar
- saverna therapeutics AG — Biotechnology · Biel-Benken BL
- Immitra Bio GmbH — Biotechnology · Plan-les-Ouates
- CRISPR Therapeutics AG — Biotechnology · Zug
Find every biotechnology company in Switzerland
Alpintel searches all 710,000 Swiss companies with AI — filter by industry, size, revenue, region and ownership in seconds.
family-owned biotechnology companies with 50+ employees…Search →Full profiles from CHF 49/month · Cancel anytime